Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
centanafadine
|
| gptkbp:approvalYear |
2024-03-28
|
| gptkbp:ATCCode |
N06BA15
|
| gptkbp:drugClass |
norepinephrine reuptake inhibitor
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cybantyx
|
| gptkbp:indication |
gptkb:attention_deficit_hyperactivity_disorder
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Trilobites
|
| gptkbp:bfsLayer |
6
|